Execupharm (India) Private Limited

Execupharm (India) Private Limited - professional services in Bangalore, Karnataka, India. Directors, charges & compliance details.
CIN U73100KA2013PTC067830 Incorporated 12 February 2013 ROC Bangalore HQ Bangalore, Karnataka, India
Struck Off Private Limited Company professional services
Revenue · FY 2017
₹33.41 Lakh
▼ 18% YoY
Net profit · FY 2017
₹4.92 Lakh
Net margin 14.7%
EBITDA · FY 2017
₹9.76 Lakh
EBITDA margin 29.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
GST registrations
1
None active

About Execupharm (India) Private Limited

Data last updated:

Execupharm (India) Private Limited was a private limited company based in Bangalore, Karnataka, India, operated as a subsidiary of Execupharm International Llc, Usa. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the personal services segment of the professional services sector. It was incorporated on 12 February 2013.

The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2013PTC067830. The company has 1 GST registration on record, which is no longer active.

The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Bharamappa Baloj and Suma Valloli Radhakrishna.

Its last annual general meeting (AGM) was held on 05 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at S – 04 1st And 2nd Floor Ibis Hotel 26/1 Hosur Road Bommanahally, Bangalore, Karnataka, India – 560068.

As per the financials filed for FY 2017, the company reported a revenue of ₹33.41 Lakh, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹4.92 Lakh (net margin 14.7%) and EBITDA of ₹9.76 Lakh (EBITDA margin 29.2%).

Company details

CIN U73100KA2013PTC067830
Registration Number 067830
Incorporation Date 12 February 2013
ROC Bangalore
Listing Status Unlisted
Company Status Struck Off
Parent Company Execupharm International Llc, Usa
Compliance Status Active Compliant

Contact details

Execupharm (India) Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    S – 04 1st And 2nd Floor Ibis Hotel 26/1 Hosur Road Bommanahally, Bangalore, Karnataka, India – 560068
  • Industry
    Professional Services, Personal, Scientific, Technical

To see the full contact details of Execupharm (India) Private Limited, buy the company report.

Comprehensive company report
Execupharm (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Execupharm (India) Private Limited

FY 2020 filings available

Execupharm (India) Private Limited reported revenue of ₹33.41 Lakh (down 18% YoY) for FY 2017.

Revenue · FY 2017
₹33.41 Lakh ▼ 18%
Net profit · FY 2017
₹4.92 Lakh margin 14.7%
EBITDA · FY 2017
₹9.76 Lakh margin 29.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 18%
EBITDA CAGR growth
1 year
▼ 15%

Revenue fell 18% in the latest year. EBITDA fell 15% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations₹33.41 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹9.76 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹4.92 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin29.2%
Net Profit Margin14.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Execupharm (India) Private Limited, buy the company report.

Board of directors of Execupharm (India) Private Limited

Execupharm (India) has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Bharamappa BalojDirector05 Aug 201412 Years 3 MonthsAs last reported
Suma Valloli RadhakrishnaDirector15 Apr 20197 Years 7 MonthsAs last reported

Auditor

Execupharm (India) Private Limited is audited by Chaturvedi & shah for the financial year 2017.

Auditor firmFinancial yearFirm registration number
Chaturvedi & shahFY 2017101720W

Shareholding

The shareholding of Execupharm (India) Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Execupharm (India) Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Execupharm (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Execupharm (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Execupharm (India) Private Limited, buy the company report.

Recent activity

Execupharm (India) Private Limited has 9 board changes on record since 2014: 2 appointments and 7 cessations. The latest: Suma Valloli Radhakrishna ceased to be Additional Director on 30 Sep 2019.

AGM
Execupharm (India) Private Limited last Annual general meeting of members was held on 05 Dec 2020 as per latest MCA records.
Filing
Execupharm (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Bangalore.
Ceased
Suma Valloli Radhakrishna ceased to be Additional Director.
Ceased
Samuel Stephen Porrecca ceased to be Director.
Appointed
Suma Valloli Radhakrishna was appointed as Director.
Ceased
Maria Larson ceased to be Director.
Ceased
Lalu John Philip ceased to be Alternate Director.
Ceased
Anthony John Peter Southers ceased to be Director.
Ceased
Scott Eric Larson ceased to be Director.
Ceased
Bharamappa Baloj ceased to be Additional Director.
Appointed
Bharamappa Baloj was appointed as Director.
Incorporation
12 Feb 2013
Execupharm (India) Private Limited was registered on 12 Feb 2013 with Roc Bangalore & aged 13 years 9 months as per MCA records.

Frequently asked questions

Execupharm (India) has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Execupharm (India) was a private limited company based in Bangalore, Karnataka, India. The company worked in personal, within the professional services industry. It was incorporated on 12 February 2013 and is registered under CIN U73100KA2013PTC067830. The company has been struck off by the Registrar of Companies and is no longer operational.

Execupharm (India) had 2 directors:

The CIN (Corporate Identification Number) of Execupharm (India) is U73100KA2013PTC067830. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Execupharm (India) is at S – 04 1st And 2nd Floor Ibis Hotel 261 Hosur Road Bommanahally, Bangalore, Karnataka, India – 560068.

Execupharm (India) was incorporated on 12 February 2013. It is registered with the Registrar of Companies, Bangalore.

The latest financial statements of Execupharm (India) on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 05 December 2020. Year-wise statements from 2015 are in the company report.

No. Execupharm (India) has 1 GST registration on record and it is cancelled or inactive.

Execupharm (India) operated in the professional services industry, in the personal segment. It worked in this industry before it was struck off.

Suma Valloli Radhakrishna ceased to be Additional Director on 30 Sep 2019. Samuel Stephen Porrecca ceased to be Director on 02 Aug 2019. Suma Valloli Radhakrishna was appointed as Director on 15 Apr 2019. Execupharm (India) has 9 board changes on record in total.